Poslední aktualizace :
29/10/2024
vėžio narkotikų   Gemcitabine hydrochloride  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Accogem Meksikas
Antoril Argentina
Axigem Vokietija
Bendacitabin Vokietija
Binoptos Meksikas
Celzar Peru
Dercin Rumunija
Dhacibine Malaizija
Emcitab Kolumbija
Eriogem Argentina, Ekvadoras
Fotinex Argentina, Peru
Gebina Argentina
Gebitan Kolumbija
Gembio Argentina, Čilė, Ekvadoras
Gemcimira Čilė, Peru
Gemcit Portugalija
Gemcitabin Vokietija
Gemcitac Čilė
Gemko Turkija
Gemsibin Turkija
Gemsol Austrija
Gemtero Čilė, Peru
Gemzar Airija, Australija, Austrija, Belgija, Brazilija, Čilė, Danija, Didžioji Britanija, Egiptas, Ekvadoras, Graikija, Iranas, Islandija, Ispanija, Italija, Jungtinės Amerikos Valstijos, Jungtiniai Arabų Emyratai, Kanada, Kolumbija, Kroatija, Lenkija, Liuksemburgas, Malaizija, Marokas, Meksikas, Naujojoje Zelandijoje, Norvegija, Olandija, Pietų Afrikos Respublika, Portugalija, Prancūzija, Rumunija, Slovėnija, Suomija, Švedija, Šveicarija, Tailandas, Tunisas, Turkija, Venesuela, Vengrija, Vokietija
Gentabin Kolumbija
Haxanit Argentina, Peru
Lenfotabin Meksikas
Bibliografija   Įpurškimas   Bibliografija : Gemcitabine hydrochloride  
tipas leidinys
1422 Žurnalas Xu QA, Zhang Y, Trissel LA.
Physical and chemical stability of gemcitabine hydrochloride solutions.
J Am Pharm Assoc 1999 ; 39: 509-513.
1423 Žurnalas Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1501 Žurnalas Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Int J Pharm 1999 ; 185: 113-121.
1520 Laboratorija Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1611 Žurnalas Chalmers JR, Bobek MB, Militello MA.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625 Žurnalas Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1662 Žurnalas Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1663 Žurnalas Ponton JL, Munoz C, Rey M, Val M.
The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection.
EJHP 2002 ; 1: 23-25.
1925 Žurnalas Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1953 Žurnalas Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 Žurnalas Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009 Žurnalas Trissel LA, Zhang Y.
Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration.
Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262 Žurnalas Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344 Laboratorija Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
Ebewe Pharma 2009
3262 Žurnalas Manners S, Galettis P, de Souza P.
Conditions causing gemcitabine crystallization.
J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496 Laboratorija Gemcitabin Actavis solution - Stability Study
Actavis 2009
3670 Žurnalas Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30.
4310 Žurnalas Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M.
Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.
Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736 Žurnalas Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L.
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions.
J Pharm Biomed Anal 2023

  Mentions Légales